Friedman Industries Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	2.45	3.69	2.89	2.99	2.6
Cash & Short-Term Investments	2.45	3.69	2.89	2.99	2.6
Cash Growth	-33.53%	27.50%	-3.38%	15.17%	-68.28%
Accounts Receivable	80.17	47.48	47.33	49.37	35.67
Other Receivables	0.52	-	-	-	-
Total Trade Receivables	80.7	47.48	47.33	49.37	35.67
Inventory	172.22	113.69	115.8	86.25	67.95
Other Current Assets	1.67	1.62	4.04	5.05	19.15
Total Current Assets	257.04	166.47	170.06	143.66	125.36
Net Property, Plant & Equipment	78.32	59.09	59.6	55.2	30.22
Other Long-Term Assets	1.45	1.26	0.36	0.45	3.69
Total Assets	336.81	226.82	230.02	199.31	159.28
Accounts Payable	67.17	35.3	43.89	36.85	44.8
Accrued Expenses	8.27	1.81	5.99	5	1.34
Current Portion of Leases	-	-	0.05	0.11	0.11
Other Current Liabilities	0.71	1.21	4.18	3.13	14.57
Total Current Liabilities	76.15	38.32	54.11	45.09	60.81
Long-Term Debt	96.05	47.73	40.29	33.12	18.44
Long-Term Leases	4.1	2.75	2.78	1.22	-
Other Long-Term Liabilities	9.02	5.59	5.36	4.45	0.34
Total Long-Term Liabilities	109.17	56.07	48.44	38.79	18.78
Total Liabilities	185.32	94.4	102.54	83.88	79.59
Common Stock	9.02	8.88	8.87	-	-
Treasury Stock	-13.11	-13.1	-12.93	-7.78	-7.74
Additional Paid-in Capital	35.93	35.39	35.25	35.01	30.44
Accumulated Other Comprehensive Income	-	-	-	-0.32	-10.27
Retained Earnings	119.65	101.25	96.28	79.65	58.91
Shareholders' Equity	151.49	132.43	127.48	115.43	79.69
Total Liabilities & Equity	336.81	226.82	230.02	199.31	159.28
Total Debt	100.15	50.48	43.13	34.45	18.54
Net Cash (Debt)	-97.7	-46.79	-40.24	-31.45	-15.94
Net Cash Per Share	-14.02	-6.74	-5.54	-4.29	-2.41
Book Value	151.49	132.43	127.48	115.43	79.69
Book Value Per Share	21.74	19.07	17.57	15.74	12.03
Tangible Book Value	151.49	132.43	127.48	115.43	79.69
Tangible Book Value Per Share	21.74	19.07	17.57	15.74	12.03

SEC Filings: 10-K · 10-Q